메뉴 건너뛰기




Volumn 9, Issue , 2014, Pages 4169-4176

Assessment and optimization of electroporation-assisted tumoral nanoparticle uptake in a nude mouse model of pancreatic ductal adenocarcinoma

Author keywords

Electroporation; In vivo; Nanoparticles; Pancreatic adenocarcinoma; Tumoral uptake

Indexed keywords

DOXORUBICIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; BIOMATERIAL; IRON; MAGNETITE NANOPARTICLE;

EID: 84930008175     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S63324     Document Type: Article
Times cited : (16)

References (18)
  • 4
    • 84877087883 scopus 로고    scopus 로고
    • Treatment options for advanced pancreatic cancer: A review
    • Warsame R, Grothey A. Treatment options for advanced pancreatic cancer: a review. Expert Rev Anticancer Ther. 2012;12:1327-1336.
    • (2012) Expert Rev Anticancer Ther , vol.12 , pp. 1327-1336
    • Warsame, R.1    Grothey, A.2
  • 5
    • 78651108985 scopus 로고    scopus 로고
    • Pancreatic cancer: Understanding and overcoming chemoresistance
    • Wang Z, Li Y, Ahmad A, et al. Pancreatic cancer: understanding and overcoming chemoresistance. Nat Rev Gastroenterol Hepatol. 2011;8:27-33.
    • (2011) Nat Rev Gastroenterol Hepatol , vol.8 , pp. 27-33
    • Wang, Z.1    Li, Y.2    Ahmad, A.3
  • 6
    • 70350635407 scopus 로고    scopus 로고
    • Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutions
    • Andersson R, Aho U, Nilsson BI, et al. Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions. Scand J Gastroenterol. 2009;44:782-786.
    • (2009) Scand J Gastroenterol , vol.44 , pp. 782-786
    • Andersson, R.1    Aho, U.2    Nilsson, B.I.3
  • 8
    • 67149143399 scopus 로고    scopus 로고
    • Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer
    • Olive K, Jacobetz MA, Davidson CJ, et al. Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009;324:1457-1461.
    • (2009) Science , vol.324 , pp. 1457-1461
    • Olive, K.1    Jacobetz, M.A.2    Davidson, C.J.3
  • 10
    • 0031856811 scopus 로고    scopus 로고
    • Electroporation enhances therapeutic efficacy of anticancer drugs: Treatment of human pancreatic tumor in animal model
    • Nanda GS, Sun FX, Hofmann GA, Hoffman RM, Dev SB. Electroporation enhances therapeutic efficacy of anticancer drugs: treatment of human pancreatic tumor in animal model. Anticancer Res. 1998;18:1361-1366.
    • (1998) Anticancer Res , vol.18 , pp. 1361-1366
    • Nanda, G.S.1    Sun, F.X.2    Hofmann, G.A.3    Hoffman, R.M.4    Dev, S.B.5
  • 11
    • 51049090204 scopus 로고    scopus 로고
    • Nanoparticle therapeutics: An emerging treatment modality for cancer
    • Davis M, Chen Z, Shin D. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7:771-782.
    • (2008) Nat Rev Drug Discov , vol.7 , pp. 771-782
    • Davis, M.1    Chen, Z.2    Shin, D.3
  • 12
    • 82255175232 scopus 로고    scopus 로고
    • Squale-noyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer
    • Réjiba S, Reddy LH, Bigand C, Parmentier C, Couvreur P, Hajri A. Squale-noyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer. Nanomedicine. 2011;7:841-849.
    • (2011) Nanomedicine , vol.7 , pp. 841-849
    • Réjiba, S.1    Reddy, L.H.2    Bigand, C.3    Parmentier, C.4    Couvreur, P.5    Hajri, A.6
  • 13
    • 0016793022 scopus 로고
    • Establishment of a continuous tumor-cell line (Panc-1) from a human carcinoma of the exocrine pancreas
    • Lieber M, Mazzetta J, Nelson-Rees W, Kaplan M, Todaro G. Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas. Int J Cancer. 1975;15:741-747.
    • (1975) Int J Cancer , vol.15 , pp. 741-747
    • Lieber, M.1    Mazzetta, J.2    Nelson-Rees, W.3    Kaplan, M.4    Todaro, G.5
  • 15
    • 84862528550 scopus 로고    scopus 로고
    • Molecular targets of gemcitabine action: Rationale for development of novel drugs and drug combinations
    • Elnaggar M, Giovannetti E, Peters GJ. Molecular targets of gemcitabine action: rationale for development of novel drugs and drug combinations. Curr Pharm Des. 2012;18(19):2811-2829.
    • (2012) Curr Pharm Des , vol.18 , Issue.19 , pp. 2811-2829
    • Elnaggar, M.1    Giovannetti, E.2    Peters, G.J.3
  • 16
    • 84863109797 scopus 로고    scopus 로고
    • Glycogen synthase kinase 3ß inhibition sensitizes pancreatic cancer cells to gemcitabine
    • Shimasaki T, Ishigaki Y, Nakamura Y, et al. Glycogen synthase kinase 3ß inhibition sensitizes pancreatic cancer cells to gemcitabine. J Gastroenterol. 2012;47:321-333.
    • (2012) J Gastroenterol , vol.47 , pp. 321-333
    • Shimasaki, T.1    Ishigaki, Y.2    Nakamura, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.